Merck and Moderna’s Intismeran Autogene Plus Keytruda Meets Phase 3 RFS and DMFS Endpoints in Resected Melanoma
FDA Grants HDE Approval to OncoSil for Distal Cholangiocarcinoma
FDA Lists More Than 1,500 AI-Enabled Medical Devices as Oncology Applications Expand
Simplify Your ESO College Enrolment With Our New 3-Year Plan - ESO
Human Connection in Cancer Care with Dr. Aleksandra Filipovic - CancerWorld
ENZAMET: Enzalutamide Maintains Long-Term Survival Benefit in mHSPC
Bridging the Care Gap: Expanding Humanitarian Access to CLL Treatment Across LMICs
oncoHUB and OncoDaily Announce Strategic Partnership to Strengthen Ukrainian Oncology
|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
1 event,
The ESMO Course in Medical Oncology for Medical Students 2026 is an interactive, four-day residential educational program taking place from July 24 to 28, 2026, in Valencia, Spain. Organized by the European Society for Medical Oncology (ESMO), the course is specifically designed for fourth and fifth-year medical students. Co-Chaired by Andrés Cervantes and Rodrigo Sanchez […] |
1 event,
Virtual Event
Virtual Event
The ESMO Guidelines: Real World Cases – Rectal Cancer 2026 webinar, organized by the European Society for Medical Oncology (ESMO), will take place on 29 July 2026 at 18:30 CEST. The session will use a real-world case to explore current ESMO recommendations for rectal cancer, including multimodality treatment, total neoadjuvant therapy, organ preservation, surgical strategies, […] |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
1 event,
Virtual Event
The ESMO Academy 2026, organized by the European Society for Medical Oncology (ESMO), will take place virtually from 3 August to 12 October 2026. The programme will combine on-demand educational modules with live interactive sessions led by ESMO faculty, covering major tumour types, clinical trial methodology, treatment principles, pharmacokinetics, drug interactions, and topics relevant to […] |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
1 event, |
2 events,
Virtual Event
Virtual Event
The ESMO Deep Dive: First-Line Therapy for HRD-Negative Advanced Ovarian Cancer 2026 webinar, organized by the European Society for Medical Oncology (ESMO), will take place live on 2 September 2026 at 18:30 CEST. The session will examine the reliability of current HRD testing, the role of PARP inhibitors in maintenance therapy, and the emerging potential […] |
1 event, |
1 event, |
1 event, |
1 event, |
